Free Trial
LON:GENI

GENinCode (GENI) Share Price, News & Analysis

GENinCode logo
GBX 1.50 -0.05 (-3.10%)
As of 07:43 AM Eastern

About GENinCode Stock (LON:GENI)

Key Stats

Today's Range
1.50
1.60
50-Day Range
1.43
3
52-Week Range
1
8.50
Volume
219,725 shs
Average Volume
729,023 shs
Market Capitalization
£2.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide. GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U. GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.

Receive GENI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GENinCode and its competitors with MarketBeat's FREE daily newsletter.

GENI Stock News Headlines

GENinCode (LON:GENI) Shares Up 3.1% - Should You Buy?
This document could hand you a shot at $915 every single weekend!
Something fascinating happens in the options market when most traders aren't paying attention… While everyone else collects standard daily premiums Monday through Friday... There's a special opportunity to target TRIPLE premiums just for holding positions over the weekend. Think about that... Most traders get one day's worth of premium for their trades. But by entering right before the weekend, when everything works out, you could collect THREE days worth - even though markets are closed for two of them. Thanks to a special discovery by a Wall Street legend who helped manage a $1.7 trillion firm – regular folks like you can now target extra cash from the markets on weekends… Just like he showed his small group of traders on December 20th with KO... A quick 2-minute setup Friday afternoon… Head out for the weekend... Monday morning? An extra $1,111 sitting in the account (with a $5k starting stake).
See More Headlines

GENI Stock Analysis - Frequently Asked Questions

GENinCode's stock was trading at GBX 3.89 at the start of the year. Since then, GENI stock has decreased by 61.4% and is now trading at GBX 1.50.
View the best growth stocks for 2025 here
.

Shares of GENI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that GENinCode investors own include QUALCOMM (QCOM), Sound Energy (SOU), Zura Bio (ZURA), Capital One Financial (COF), Lincoln National (LNC), Ovid Therapeutics (OVID) and Plug Power (PLUG).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
Entertainment
Current Symbol
LON:GENI
CIK
N/A
Fax
N/A
Employees
2,300
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£6.10 million
Net Margins
-228.70%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£2.67 million
Cash Flow
GBX 1.80 per share
Price / Cash Flow
0.83
Book Value
GBX 1.63 per share
Price / Book
0.92

Miscellaneous

Free Float
N/A
Market Cap
£2.66 million
Optionable
Not Optionable
Beta
0.66
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (LON:GENI) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners